News

Impax Laboratories and its subsidiary ThoRx Laboratories have been challenged by US-based Endo Pharmaceuticals and German’s Grunenthal on 14 November 2012, regarding the patents of Opana® ER tablets,

With the move the company plans to increase its foothold in the US with the help of existing European and US pharmaceutical regulations. SDI America president Danny Cusick

According to the company the increased loss is due to the $155,000 increase in general and administration expenses, a $33,000 increase in business development expenses and a $28,000

The new facility for Shanghai Promega Biological Products will replace present molecular biology reagent production site and also provide additional research, development and cGMP manufacturing capabilities for molecular

As part of Series B financing, the firm has already raised about $25m from pharmaceutical major Eli Lilly and global financial services firm Fidelity. With plans underway to

As part of a distribution agreement between Mikah and Actavis, Actavis will distribute Phendimetrazine tartrate 35 mg tablets, which are equivalent to generic version of Bontril PDM(R) 35 mg tablets.

The company won regulatory authorisation to advance the trials in October, from Medsafe. Living Cell Technologies chief executive Dr Andrea Grant said the ethical approval was granted in

The 25,000ft² laboratory, which represents LGC latest genomics investment, will carry out manufacturing operations of the firm’s reagents and laboratory products. LGC chief executive David Richardson said the

The open-label study enrolled 24 patients undergoing robotic prostatectomy to assess the safety and efficacy profile of bupivacaine liposome injectable suspension by means of TAP infiltration. Prospective study